Anti-obesity Medication Market Size, Share & Trends Analysis Report By Product (Approved, Off Label), By Mechanism of Action (Peripherally Acting Drugs, Centrally Acting Drugs), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Ismail Sutaria | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Anti-obesity Medication Market Size Analysis
    1. Introduction
    2. Anti-obesity Medication Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Approved
        1. Bupropion-naltrexone (Contrave)
        2. Liraglutide (Orlistat)
        3. Orlistat
          1. Xenical
          2. Alli
        4. Phentermine-topiramate (Qsymia)
        5. Semaglutide (Wegovy)
        6. Setmelanotide (Imcivree)
        7. Tirzepatide (Zepbound)
      2. Off Label
        1. Semaglutide (Xenical Alli)
        2. Liraglutide (Semaglutide (Wegovy))
        3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
        4. Others
    3. Anti-obesity Medication Market Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
      1. Peripherally Acting Drugs
      2. Centrally Acting Drugs
    4. Anti-obesity Medication Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Retail Pharmacies
      2. Hospital Pharmacies
      3. Others
  7. North America Anti-obesity Medication Market Size Analysis
    1. Introduction
    2. Anti-obesity Medication Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Approved
        1. Bupropion-naltrexone (Contrave)
        2. Liraglutide (Orlistat)
        3. Orlistat
          1. Xenical
          2. Alli
        4. Phentermine-topiramate (Qsymia)
        5. Semaglutide (Wegovy)
        6. Setmelanotide (Imcivree)
        7. Tirzepatide (Zepbound)
      2. Off Label
        1. Semaglutide (Xenical Alli)
        2. Liraglutide (Semaglutide (Wegovy))
        3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
        4. Others
    3. Anti-obesity Medication Market Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
      1. Peripherally Acting Drugs
      2. Centrally Acting Drugs
    4. Anti-obesity Medication Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Retail Pharmacies
      2. Hospital Pharmacies
      3. Others
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
  8. Europe Anti-obesity Medication Market Size Analysis
    1. Introduction
    2. Anti-obesity Medication Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Approved
        1. Bupropion-naltrexone (Contrave)
        2. Liraglutide (Orlistat)
        3. Orlistat
          1. Xenical
          2. Alli
        4. Phentermine-topiramate (Qsymia)
        5. Semaglutide (Wegovy)
        6. Setmelanotide (Imcivree)
        7. Tirzepatide (Zepbound)
      2. Off Label
        1. Semaglutide (Xenical Alli)
        2. Liraglutide (Semaglutide (Wegovy))
        3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
        4. Others
    3. Anti-obesity Medication Market Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
      1. Peripherally Acting Drugs
      2. Centrally Acting Drugs
    4. Anti-obesity Medication Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Retail Pharmacies
      2. Hospital Pharmacies
      3. Others
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
    7. France
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
  9. APAC Anti-obesity Medication Market Size Analysis
    1. Introduction
    2. Anti-obesity Medication Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Approved
        1. Bupropion-naltrexone (Contrave)
        2. Liraglutide (Orlistat)
        3. Orlistat
          1. Xenical
          2. Alli
        4. Phentermine-topiramate (Qsymia)
        5. Semaglutide (Wegovy)
        6. Setmelanotide (Imcivree)
        7. Tirzepatide (Zepbound)
      2. Off Label
        1. Semaglutide (Xenical Alli)
        2. Liraglutide (Semaglutide (Wegovy))
        3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
        4. Others
    3. Anti-obesity Medication Market Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
      1. Peripherally Acting Drugs
      2. Centrally Acting Drugs
    4. Anti-obesity Medication Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Retail Pharmacies
      2. Hospital Pharmacies
      3. Others
    5. China
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
    8. India
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
    10. Singapore
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
  10. Middle East and Africa Anti-obesity Medication Market Size Analysis
    1. Introduction
    2. Anti-obesity Medication Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Approved
        1. Bupropion-naltrexone (Contrave)
        2. Liraglutide (Orlistat)
        3. Orlistat
          1. Xenical
          2. Alli
        4. Phentermine-topiramate (Qsymia)
        5. Semaglutide (Wegovy)
        6. Setmelanotide (Imcivree)
        7. Tirzepatide (Zepbound)
      2. Off Label
        1. Semaglutide (Xenical Alli)
        2. Liraglutide (Semaglutide (Wegovy))
        3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
        4. Others
    3. Anti-obesity Medication Market Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
      1. Peripherally Acting Drugs
      2. Centrally Acting Drugs
    4. Anti-obesity Medication Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Retail Pharmacies
      2. Hospital Pharmacies
      3. Others
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
  11. LATAM Anti-obesity Medication Market Size Analysis
    1. Introduction
    2. Anti-obesity Medication Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Approved
        1. Bupropion-naltrexone (Contrave)
        2. Liraglutide (Orlistat)
        3. Orlistat
          1. Xenical
          2. Alli
        4. Phentermine-topiramate (Qsymia)
        5. Semaglutide (Wegovy)
        6. Setmelanotide (Imcivree)
        7. Tirzepatide (Zepbound)
      2. Off Label
        1. Semaglutide (Xenical Alli)
        2. Liraglutide (Semaglutide (Wegovy))
        3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
        4. Others
    3. Anti-obesity Medication Market Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
      1. Peripherally Acting Drugs
      2. Centrally Acting Drugs
    4. Anti-obesity Medication Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Retail Pharmacies
      2. Hospital Pharmacies
      3. Others
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Approved
          1. Bupropion-naltrexone (Contrave)
          2. Liraglutide (Orlistat)
          3. Orlistat
            1. Xenical
            2. Alli
          4. Phentermine-topiramate (Qsymia)
          5. Semaglutide (Wegovy)
          6. Setmelanotide (Imcivree)
          7. Tirzepatide (Zepbound)
        2. Off Label
          1. Semaglutide (Xenical Alli)
          2. Liraglutide (Semaglutide (Wegovy))
          3. Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity)
          4. Others
      3. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Peripherally Acting Drugs
        2. Centrally Acting Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Others
  12. Competitive Landscape
    1. Anti-obesity Medication Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Novo Nordisk A/S
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. GlaxoSmithKline plc
    3. Novartis AG
    4. VIVUS LLC
    5. Currax Pharmaceuticals
    6. Kintai Therapeutics
    7. Boehringer Ingelheim International GmbH
    8. Rhythm Pharmaceuticals, Inc.
    9. Gelesis
    10. Hoffmann-La Roche Ltd
    11. Eli Lilly and Company
    12. Pfizer Inc.
    13. AstraZeneca plc
    14. Amgen Inc.
    15. Viking Therapeutics, Inc.
    16. Zealand Pharma A/S
    17. Weight Loss Biotech
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  16. Disclaimer

List of Tables

Table 1: Global Anti-obesity Medication Market Size and Forecast By Regions - 2022-2034 (USD Billion)

Table 2: Global Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 3: Global Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 4: Global Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 5: North America Anti-obesity Medication Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 6: North America Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 7: North America Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 8: North America Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 9: U.S. Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 10: U.S. Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 11: U.S. Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 12: Canada Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 13: Canada Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 14: Canada Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 15: Europe Anti-obesity Medication Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 16: Europe Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 17: Europe Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 18: Europe Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 19: U.K. Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 20: U.K. Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 21: U.K. Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 22: Germany Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 23: Germany Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 24: Germany Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 25: France Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 26: France Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 27: France Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 28: Spain Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 29: Spain Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 30: Spain Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 31: Italy Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 32: Italy Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 33: Italy Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 34: Russia Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 35: Russia Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 36: Russia Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 37: Nordic Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 38: Nordic Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 39: Nordic Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 40: Benelux Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 41: Benelux Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 42: Benelux Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 43: Rest of Europe Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 44: Rest of Europe Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 45: Rest of Europe Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 46: APAC Anti-obesity Medication Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 47: APAC Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 48: APAC Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 49: APAC Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 50: China Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 51: China Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 52: China Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 53: Korea Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 54: Korea Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 55: Korea Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 56: Japan Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 57: Japan Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 58: Japan Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 59: India Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 60: India Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 61: India Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 62: Australia Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 63: Australia Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 64: Australia Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 65: Singapore Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 66: Singapore Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 67: Singapore Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 68: Taiwan Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 69: Taiwan Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 70: Taiwan Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 71: South East Asia Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 72: South East Asia Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 73: South East Asia Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 74: Rest of Asia-Pacific Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 75: Rest of Asia-Pacific Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 76: Rest of Asia-Pacific Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 77: Middle East and Africa Anti-obesity Medication Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 78: Middle East and Africa Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 79: Middle East and Africa Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 80: Middle East and Africa Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 81: UAE Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 82: UAE Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 83: UAE Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 84: Turkey Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 85: Turkey Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 86: Turkey Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 87: Saudi Arabia Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 88: Saudi Arabia Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 89: Saudi Arabia Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 90: South Africa Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 91: South Africa Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 92: South Africa Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 93: Egypt Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 94: Egypt Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 95: Egypt Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 96: Nigeria Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 97: Nigeria Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 98: Nigeria Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 99: Rest of MEA Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 100: Rest of MEA Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 101: Rest of MEA Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 102: LATAM Anti-obesity Medication Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 103: LATAM Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 104: LATAM Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 105: LATAM Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 106: Brazil Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 107: Brazil Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 108: Brazil Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 109: Mexico Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 110: Mexico Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 111: Mexico Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 112: Argentina Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 113: Argentina Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 114: Argentina Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 115: Chile Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 116: Chile Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 117: Chile Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 118: Colombia Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 119: Colombia Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 120: Colombia Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 121: Rest of LATAM Anti-obesity Medication Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 122: Rest of LATAM Anti-obesity Medication Market Size and Forecast By Mechanism of Action - 2022-2034 (USD Billion)

Table 123: Rest of LATAM Anti-obesity Medication Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

We are featured on: